When MRD testing evolves from a numerical readout into a definition of clonal behavior, it becomes what clinicians have needed all along: a tool that informs action, not just detection.Two patients with acute myeloid leukemia (AML) achieve remission. Both test positive for measurable residual disease (MRD). Both show the same mutation at a similar variant […]
